Dr Buckley’s research focuses on understanding the pathways driving breast and ovarian cancer with a particular focus on triple negative breast cancer and the breast and ovarian tumour suppressor gene, BRCA1.

Dr Buckley’s stratified medicine approach integrates in vitro, in vivo, bioinformatics and molecular pathology methodologies to analyse tumours, identifying key pathways underpinning poor outcome.

Detailed knowledge of this biology is then used to identify appropriate targeted treatment options, personalising therapy in an area of unmet clinical need.